Your session is about to expire
← Back to Search
Virtual vs In-Person Quit Smoking Programs for Tobacco Use (CEASE Trial)
N/A
Recruiting
Research Sponsored by Morgan State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Current smokers
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week19 from enrollment (12 weeks after the last peer-motivation session)
Awards & highlights
CEASE Trial Summary
This trialis testing the effectiveness of virtual and in-person versions of a smoking cessation program to reduce tobacco use in low-income communities in Baltimore City. Trained peer-motivators deliver the intervention, which includes a CEASE website and manual, to help people quit smoking.
Who is the study for?
Adults aged 21+ who currently smoke and are ready to quit can join this trial. They must consent to participate and, for the virtual program, have access to a device with internet or cellular data. People cannot join if they're unable to consent due to health conditions or lack device access in areas assigned the virtual intervention.Check my eligibility
What is being tested?
The study is testing how effective virtual peer-motivation smoking cessation programs are compared to enhanced in-person ones across three communities in Baltimore City. Participants will be randomly placed into either a virtual program, an in-person program, or a control group that receives self-help materials.See study design
What are the potential side effects?
Since this trial involves behavioral interventions rather than medications, traditional side effects like those seen with drugs aren't expected. However, participants may experience stress or discomfort related to quitting smoking.
CEASE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
You are currently smoking cigarettes.
CEASE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week19 from enrollment (12 weeks after the last peer-motivation session)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week19 from enrollment (12 weeks after the last peer-motivation session)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Self-reported smoking cessation verified by expired-air Carbon Monoxide (CO) level (self-help group).
Self-reported smoking cessation verified by expired-air Carbon Monoxide (CO) level (virtual and in-person groups).
Secondary outcome measures
Retention
CEASE Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Virtual peer-motivationExperimental Treatment1 Intervention
This is a seven-week tobacco cessation program and will be offered virtually (except first two sessions: orientation and technology set-up) weekly for seven weeks and will utilize a newly developed website with smoking cessation modules that mirrors lessons of the CEASE Today Tobacco Cessation Manual.
Group II: Enhanced in-person peer-motivationExperimental Treatment1 Intervention
This is a seven-week tobacco cessation program and will be offered in-person weekly for seven weeks and will utilize the CEASE Today Tobacco Cessation Manual.
Group III: Self-help/ControlActive Control1 Intervention
The participants in the control group will receive the services already in place, including a brief motivation enhancement session.
Find a Location
Who is running the clinical trial?
National Institute on Minority Health and Health Disparities (NIMHD)NIH
373 Previous Clinical Trials
1,213,826 Total Patients Enrolled
Morgan State UniversityLead Sponsor
2 Previous Clinical Trials
2,130 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are currently smoking cigarettes.
Research Study Groups:
This trial has the following groups:- Group 1: Virtual peer-motivation
- Group 2: Self-help/Control
- Group 3: Enhanced in-person peer-motivation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger